European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 42049597.
- Also identified by DOI 10.1016/j.eururo.2026.03.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The European Association of Urology (EAU) produces an annual guidelines document based on the most recent evidence for the diagnosis, treatment, and follow-up of testicular cancer (TC). To summarize the 2026 version of the EAU Guidelines on TC and highlight the main changes compared to the previous version. A multidisciplinary team of clinicians with specific expertise in the disease (urologists, medical oncologists, radiation oncologists, and pathologists) reviewed the results of a comprehensive appraisal of the published literature on the topic since the last Guidelines update paper in 2023. Recommendations based on the highest available level of evidence are presented across TC stages, histologies and prognostic categories regarding diagnosis, primary management, detection and treatment of relapse and survivorship care. Areas of lack of strong recommendation consensus are highlighted. The 2026 version of the EAU Guidelines on TC collates the highest available scientific evidence to standardize the management of patients with TC.